Advertisement

Topics

ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2017 Financial Results

21:07 EDT 14 Jul 2017 | Biotech-Finances

Friday, July 14th 2017 at 12:00pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, July 28, 2017, to discuss its second quarter 2017 financial …

Cet article ImmunoGen Announces Conference Call to Discuss Its Second Quarter
2017 Financial Results
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2017 Financial Results

NEXT ARTICLE

More From BioPortfolio on "ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2017 Financial Results"

Quick Search
Advertisement
 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...